There's been another twist to the tale of Advanz Pharma's efforts to keep its primary biliary cholangitis (PBC) therapy Ocaliva on the market in the EU.

EU releases proposed pharma overhaul, cutting period of market exclusivity. By Andrew Joseph April 26, 2023. Reprints. Sean Gallup/Getty Images.

Novartis chief criticises EU move to control pharma licensing in emergencies on whatsapp (opens in a new window) Save. Donato Paolo Mancini and Hannah Kuchler in London. April 25 2023.